Sinovac Biotech Co., Ltd

This study aims to see if a new experimental vaccine against four types of bacterial meningitis (A, C, Y, W135) works as well and is as safe as an already approved vaccine. It will involve 1,040 healthy children aged 12 to 23 months. Researchers will compare the immune response a…

This is an early safety study for a new vaccine designed to protect against Respiratory Syncytial Virus (RSV). The trial will enroll 60 healthy adults to test different doses of a freeze-dried mRNA vaccine. Researchers will closely monitor participants for any side effects after …

This study aims to confirm that three different production batches of a rabies vaccine produce a consistent immune response. It will enroll 912 healthy adults aged 18-45, who will receive a standard 5-dose vaccination schedule. Researchers will measure antibody levels and monitor…